Cargando…
Reassessment of areas with persistent Lymphatic Filariasis nine years after cessation of mass drug administration in Sri Lanka
BACKGROUND: Sri Lanka was one of the first countries to initiate a lymphatic filariasis (LF) elimination program based on WHO guidelines. The Anti-Filariasis Campaign provided 5 annual rounds of mass drug administration (MDA) with diethylcarbamazine plus albendazole in all 8 endemic districts from 2...
Autores principales: | Rao, Ramakrishna U., Samarasekera, Sandhya D., Nagodavithana, Kumara C., Dassanayaka, Tharanga D. M., Punchihewa, Manjula W., Ranasinghe, Udaya S. B., Weil, Gary J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5679644/ https://www.ncbi.nlm.nih.gov/pubmed/29084213 http://dx.doi.org/10.1371/journal.pntd.0006066 |
Ejemplares similares
-
Programmatic Use of Molecular Xenomonitoring at the Level of Evaluation Units to Assess Persistence of Lymphatic Filariasis in Sri Lanka
por: Rao, Ramakrishna U., et al.
Publicado: (2016) -
Comprehensive Assessment of a Hotspot with Persistent Bancroftian Filariasis in Coastal Sri Lanka
por: Rao, Ramakrishna U., et al.
Publicado: (2018) -
Systematic sampling of adults as a sensitive means of detecting persistence of lymphatic filariasis following mass drug administration in Sri Lanka
por: Rao, Ramakrishna U., et al.
Publicado: (2019) -
A Comprehensive Assessment of Lymphatic Filariasis in Sri Lanka Six Years after Cessation of Mass Drug Administration
por: Rao, Ramakrishna U., et al.
Publicado: (2014) -
Morbidity management and disability prevention for lymphatic filariasis in Sri Lanka: Current status and future prospects
por: Chandrasena, Nilmini, et al.
Publicado: (2018)